Askarian Mehrdad, Reza Moravveji Ali, Assadian Ojan
Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Am J Infect Control. 2007 May;35(4):260-2. doi: 10.1016/j.ajic.2006.04.214.
To assess the appropriateness of surgical antibiotic prophylaxis in neurosurgical procedures, using the American Society of Health-System Pharmacists (ASHP) guideline as reference, 110 patients were prospectively evaluated. Monitoring surgical antibiotic prophylaxis is crucial in ensuring appropriate use of antimicrobial agents in this setting. This will minimize the consequences of antibiotic misuse such as increased drug antibiotic resistance, adverse events, and higher costs to the institution.
We recruited 110 consecutive patients undergoing clean neurosurgical treatment in 2 hospitals. Data were collected prospectively from patients' medical records between February 2004 and April 2004. The data collection forms for each patient included hospital name, patient demographics, type of surgery, and type of antimicrobial prophylaxis regimen (drug name, dose, interval, route of administration, number of doses and time administered, and duration of administration).
Discrepancies about antibiotic selection, duration, and start time of prophylaxis were seen between current administration and the ASHP guideline. The direct cost of prophylactic antibiotics for the 110 procedures was 14 times greater than what it would have cost to administer prophylactic antibiotics adhering to the ASHP guideline (US $802 vs US $59; US $7.29 vs US $0.54 per patient, respectively). This is equivalent to US $6.75 of extra costs per procedure and patient.
This study indicates the need for interventions to improve the rational use of antibiotic prophylaxis in Iran to prevent the complications of inappropriate administration of antimicrobials and decrease unnecessary costs.
为了以美国卫生系统药师协会(ASHP)指南为参考,评估神经外科手术中预防性使用抗生素的合理性,我们对110例患者进行了前瞻性评估。监测手术预防性使用抗生素对于确保在此情况下合理使用抗菌药物至关重要。这将使抗生素滥用的后果降至最低,如增加耐药性、不良事件以及给医疗机构带来更高成本。
我们招募了两家医院中连续接受清洁神经外科治疗的110例患者。在2004年2月至2004年4月期间,前瞻性地从患者病历中收集数据。每位患者的数据收集表包括医院名称、患者人口统计学信息、手术类型以及抗菌预防方案的类型(药物名称、剂量、间隔时间、给药途径、给药剂量和时间以及给药持续时间)。
当前用药情况与ASHP指南在抗生素选择、预防持续时间和开始时间方面存在差异。110例手术预防性使用抗生素的直接成本比按照ASHP指南使用预防性抗生素的成本高出14倍(分别为802美元对59美元;每位患者7.29美元对0.54美元)。这相当于每例手术和每位患者额外花费6.75美元。
本研究表明需要采取干预措施,以改善伊朗预防性使用抗生素的合理程度,预防抗菌药物使用不当的并发症并降低不必要的成本。